107688-86-8 Usage
Uses
Used in Pharmaceutical Industry:
N,N-dimethyl-3-(o-tolyloxy)-3-phenyl-propylamine oxalate is used as an active pharmaceutical ingredient for the development of medications targeting the central nervous system. Its role as a norepinephrine reuptake inhibitor makes it a promising candidate for the treatment of conditions such as attention deficit hyperactivity disorder (ADHD) and other related disorders.
Used in Research and Development:
In the field of scientific research, N,N-dimethyl-3-(o-tolyloxy)-3-phenyl-propylamine oxalate serves as a valuable compound for studying the mechanisms of norepinephrine reuptake inhibition and its potential effects on various neurological and psychiatric conditions. N,N-dimethyl-3-(o-tolyloxy)-3-phenyl-propylamine oxalate can be utilized in the design and synthesis of new drugs with improved efficacy and reduced side effects.
Used in Drug Delivery Systems:
Similar to Gallotannin, N,N-dimethyl-3-(o-tolyloxy)-3-phenyl-propylamine oxalate can also be incorporated into novel drug delivery systems to enhance its bioavailability, delivery, and therapeutic outcomes. The development of advanced drug delivery systems, such as organic and metallic nanoparticles, can help improve the compound's performance in treating specific conditions and reduce potential side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 107688-86-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,6,8 and 8 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 107688-86:
(8*1)+(7*0)+(6*7)+(5*6)+(4*8)+(3*8)+(2*8)+(1*6)=158
158 % 10 = 8
So 107688-86-8 is a valid CAS Registry Number.
107688-86-8Relevant academic research and scientific papers
A PROCESS FOR THE PREPARATION OF ATOMOXETINE HYDROCHLORIDE
-
Page/Page column 7-8, (2008/06/13)
Provided is the process for the preparation of Atomoxetine hydrochloride by the condensation of N,N-dimethyl 3-phenyl-3-chloropropyl amine acid addition salt with o- cresol in presence of a phase transfer catalyst and base followed by demethylation and resolution. Also provided preparation of crystalline Atomoxetine hydrochloride.
